Trial · NCT01823016
A Study of JNJ-38518168 in Symptomatic Adult Participants With Uncontrolled, Persistent Asthma
NCT01823016, Phase 2, Completed, Janssen Research & Development, LLC
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Study of JNJ-38518168 in Symptomatic Adult Participants With Uncontrolled, Persistent Asthma. Trials, record NCT01823016. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01823016
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Study of JNJ-38518168 in Symptomatic Adult Participants With Uncontrolled, Persistent Asthma
- NCT number
- NCT01823016
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 166 participants, actual
- Lead sponsor
- Janssen Research & Development, LLC
- Conditions
- Asthma
- Interventions
- Placebo, JNJ-38518168
- First posted
- 2013-04-04
- Last updated
- 2025-04-29
- Other registries' IDs
- eudract:2012-004920-39
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change from baseline in prebronchodilator forced expiratory volume in 1 second (preBD FEV1) | Baseline to Week 16 | Expressed as percent of predicted value. |
| Secondary | Change from baseline in Asthma Control Questionnaire (ACQ) | Baseline to Week 16 | ACQ evaluates clinical impairment that participants with asthma may experience. Items are scored on a 7-point scale (0 = good control, 6 = poor control). Higher mean scores reflect poorer control. |
| Secondary | Change from baseline in postbronchodilator forced expiratory volume in 1 second (postBD FEV1) | Baseline to Week 16 | Expressed as percent of predicted value. |
| Secondary | Change from baseline in weekly average of daytime asthma diary symptom scores | Baseline to Week 16 | Asthma diaries include questions about the frequency/severity of symptoms and impact on activities. Higher scores indicate more asthma symptoms. |
| Secondary | Change from baseline in weekly average of nighttime asthma diary symptom scores | Baseline to Week 16 | Asthma diaries include questions about number of nocturnal awakenings. |
| Secondary | Change from baseline in weekly average of number of puffs in a day that rescue medication is used | Baseline to Week 16 |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 30102965 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01823016
GET https://conductscience.org/api/trials/v1/NCT01823016/registered